Bullous pemphigoid

Exam relevance: in 9 of more than 50 board exam reports · rank 12

Synonyms
pemphigoid, autoimmune blistering disease
Specialty
Dermatology · Blistering diseases
Images
Clinical 3 · Histology 2
In the app
4 flashcards
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (5)
  2. Definition
  3. Classification
  4. Clinical features
  5. Diagnosis
  6. Differential diagnoses
  7. Treatment principles
  8. Keep learning in the app
  9. References (selection)
  10. Cross-references

Images (5)

Bullous pemphigoid – clinical photo: urticarial plaques and scattered blisters on the back of an 88-year-old man
urticarial plaques and scattered blisters on the back of an 88-year-old manHansmuller, “Bullous pemphigoid - male patient - 88 years old, 2005”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Bullous pemphigoid – clinical photo: tense, partly haemorrhagic blisters on an erythematous base on the lower leg
tense, partly haemorrhagic blisters on an erythematous base on the lower legMohammad2018, “Bullous pemphigoid new image”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Bullous pemphigoid – clinical photo: tense blisters, erosions and crusts on the leg of a bedridden 72-year-old woman
tense blisters, erosions and crusts on the leg of a bedridden 72-year-old womanAshashyou, “Bullous pemphgoid in a 72 year old bedridden female2”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Bullous pemphigoid – histology (H&E): subepidermal cleft with intact epidermis forming the blister roof, eosinophil-rich infiltrate in the blister cavity and upper dermisHistology
histology (H&E): subepidermal cleft with intact epidermis forming the blister roof, eosinophil-rich infiltrate in the blister cavity and upper dermisSarahkayb, “Skin Pemphigoid Medium Magnification”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Bullous pemphigoid – histology (H&E), detail from a published figure with markers: denuded papillary dermis with a sparse perivascular round-cell infiltrate; eosinophils and the subepidermal blister cannot …Histology
histology (H&E), detail from a published figure with markers: denuded papillary dermis with a sparse perivascular round-cell infiltrate; eosinophils and the subepidermal blister cannot …Giang et al., “Micrograph of infiltrate in bullous pemphigoid”, CC BY 4.0, via Wikimedia Commons · CC BY 4.0 · Source
1 / 5

Definition

Bullous pemphigoid is the most common form of autoimmune subepidermal blistering disease.

Autoantibodies: linear deposition along the basement membrane zone of IgG and C3 in a linear, n-serrated pattern against hemidesmosomes or against BP180 & BP230. In immunofluorescence, the salt-split skin method is used to demonstrate antibody deposition on the blister roof by achieving a separation at the lamina Lucida of the basement membrane through NaCl solution. This allows the disease to be distinguished from Epidermolysis Bullosa Acquisita (here antibodies at the blister floor).

Classification

Pre-bullous urticarial stage (Key symptom: itching)

This stage often precedes blister formation by weeks to months.

  • Clinical presentation: Urticarial plaques with eczema-like papules.
  • Diagnostic relevance: This stage is usually NOT clinically interpreted as a Blistering disease, which leads to diagnostic delays.

Pathophysiology: Although antibodies against BP180/230 are already present, histologically an inflammatory infiltrate (especially Eosinophils) and an incipient damage to the dermoepidermal junction zone without macroscopic blisters are observed. /

Clinical features

Clinical Characteristics (Differentiation from Pemphigus)

Typical age of onset is > 60 years.

Epidemiology and age peak: Bullous pemphigoid is the most common autoimmune blistering disease; incidence rises steeply beyond the age of 70. Pemphigus vulgaris, by contrast, usually manifests between the ages of 30 and 60 — the age peak is therefore one of the simplest features distinguishing the two diseases.

Blister morphology: The blisters are tense and stable, as the separation occurs subepidermal.

  • Localization: Especially trunk and flexural areas. Palms and soles are rarely affected.
  • Accompanying symptoms: Itching is typical, while mucous membranes are rarely affected. The general condition is usually relatively good (often reduced in Pemphigus vulgaris).

Further points: Nikolsky-1 is negative, Nikolsky-2 (Asboe-Hansen) is usually positive: pressure on an existing blister distends the subepidermal cleavage plane, so the blister spreads sideways.

Diagnosis

Diagnostic Pitfall: Negative Direct Immunofluorescence

  • Consequence when DIF is negative but the clinical picture fits: add serology — BP180-NC16A ELISA (correlates with disease activity) and BP230 ELISA — plus indirect immunofluorescence on monkey oesophagus and on salt-split skin (in BP fluorescence at the blister roof). If everything remains unclear: re-biopsy from freshly inflamed perilesional skin.

Differential diagnoses

Image credits for the thumbnails
  • Urticaria: Gzzz, “Urticaria child”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Pemphigus vulgaris: Mohammad2018, CC BY-SA 4.0, via Wikimedia Commons, cropped · CC BY-SA 4.0 · Source
  • Scabies: Gzzz, “Scabies hand and fingers 1”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Dermatitis herpetiformis (Duhring disease): BallenaBlanca, “Dermatitis Herpetiforme 2”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Epidermolysis bullosa acquisita: Szymański, Kowalewski, Pietrzyk et al. (2023), “Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review”, CC BY 4.0, via Wikimedia Commons · CC BY 4.0 · Source
  • Linear IgA dermatosis: Mohammad2018, “IgA bullous dermatosis”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Pemphigoid gestationis: Chen RE, Yokoyama CC, Anadkat MJ (JAAD Case Rep 2023), CC BY 4.0, via PubMed Central (PMC10568228) · CC BY 4.0 · Source

Treatment principles

  • Treatment depends on severity: mild disease is treated with potent topical glucocorticoids, and moderate to severe disease usually additionally with systemic glucocorticoids.
  • Immunosuppressants or antibiotics with anti-inflammatory activity are added as steroid-sparing agents, the latter particularly in elderly, multimorbid patients.
  • In refractory cases, intravenous immunoglobulins, immunoadsorption and biologics are available; potentially triggering medications are reviewed.

Guideline: AWMF guideline register (no. 013-071)

Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.

Keep learning in the app

In the DermaFuchs app you can learn Bullous pemphigoid with flashcards, exam questions and spot-the-diagnosis – free, in your browser or as an app.

Test yourself: Spot-diagnosis quiz with real cases →

In the app: 4 flashcards

Open in browser  Download on the App Store

References (selection)

  1. AWMF S2k Pemphigus 2023
  2. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
  3. Bullous pemphigoid
  4. DermNet: Bullous pemphigoid

Cross-references

Keep learning: test yourself

One question from the DermaFuchs app on Bullous pemphigoid – tap an answer.

Question 1 of 1

Which type of inflammatory cell is especially noted in the histological infiltrate of bullous pemphigoid?

Answer

Correct: Eosinophils. Eosinophils are prominent in the inflammatory infiltrate of bullous pemphigoid, even before blister formation.

More questions like these – with explanations and spaced repetition – in the app.

Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.